A team of researchers led by Xianghong Jasmine Zhou, PhD, professor of Pathology and Laboratory Medicine at UCLA's David Geffen School of Medicine, has made significant progress in addressing one of the primary obstacles in cell-free DNA (cfDNA) testing, popularly known as liquid biopsy.
Washington [US], August 1 (ANI): Georgetown Lombardi Comprehensive Cancer Center researchers found that studying tags, or modifications to cell-free DNA (cfDNA), may lead to a better understanding of how to assess, and possibly modulate, treatment approaches for cancer and other diseases.
Washington [US], July 27 (ANI): Researchers at Georgetown Lombardi Comprehensive Cancer Center believe that studying tags, or modifications to cell-free DNA (cfDNA), might lead to a better understanding of how to assess, and possibly modulate, treatment approaches for cancer and other diseas